Developing new chemical tools for fast biological reactions
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
This study is all about developing new tools that help scientists tag and track proteins in cells more easily and quickly, which can improve our understanding of how proteins work and help find new targets for treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11261303 on NIH RePORTER |
What this research studies
This research focuses on creating innovative chemical tools that utilize tetrazine ligation, which is the fastest known bioorthogonal reaction. The project aims to synthesize and couple minimalist tetrazines to various molecules, including chemical probes and fluorescent reporters, to enhance their functionality. It also explores the development of tetrazines that can tag proteins for purification and subsequent chemical reactions. By improving the efficiency of these reactions in cellular environments, the research seeks to advance methods for studying protein dynamics and identifying proteomic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from advanced biological therapies and diagnostics, particularly in microbiology and immunology.
Not a fit: Patients with conditions unrelated to the biological mechanisms being studied or those not requiring advanced therapeutic interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tools for studying and treating diseases at the molecular level.
How similar studies have performed: Previous research has shown promise in using bioorthogonal chemistry for various applications, indicating that this approach could yield significant advancements.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Fox, Joseph M — University of Delaware
- Study coordinator: Fox, Joseph M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.